Heat Biologics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Heat Biologics and buy or sell other stocks, ETFs, and their options commission-free!About HTBX
Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness.
CEOJeff A. Wolf, MBA
CEOJeff A. Wolf, MBA
Employees90
Employees90
HeadquartersSan Antonio, Texas
HeadquartersSan Antonio, Texas
Founded2008
Founded2008
Employees90
Employees90
HTBX Key Statistics
Market cap4.71M
Market cap4.71M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume20.13K
Average volume20.13K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.80
52 Week high$0.80
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
As of today, Heat Biologics(HTBX) shares are valued at $0.38. The company's market cap stands at 4.71M.
On 2025-12-12, Heat Biologics(HTBX) stock opened at —, reached a high of —, and a low of —.
The Heat Biologics(HTBX)'s current trading volume is 0, compared to an average daily volume of 20.13K.
In the last year, Heat Biologics(HTBX) shares hit a 52-week high of $0.80 and a 52-week low of $0.00.
In the last year, Heat Biologics(HTBX) shares hit a 52-week high of $0.80 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own HTBX. This list is generated using Robinhood data, and it’s not a recommendation.